个体化基因组医学与赋权话语。
Personalized genomic medicine and the rhetoric of empowerment.
出版信息
Hastings Cent Rep. 2012 Sep-Oct;42(5):34-40. doi: 10.1002/hast.65.
Abstract
Advocates of “personalized” genomic medicine maintain that it is revolutionary not just in what it can reveal to us, but in how it will enable us to take control of our health. But we should not assume that patient empowerment always yields positive outcomes. To assess the social impact of personalized medicine, we must anticipate how the virtue might go awry in practice.
摘要
“个性化”基因组医学的倡导者认为，它不仅在能为我们揭示的内容上具有革命性，而且在能让我们控制自身健康的方式上也具有革命性。但是，我们不应该假设赋予患者权力总是会产生积极的结果。要评估个性化医学的社会影响，我们必须预测这一美德在实践中可能会出现的偏差。
相似文献
1
Personalized genomic medicine and the rhetoric of empowerment.
Hastings Cent Rep. 2012 Sep-Oct;42(5):34-40. doi: 10.1002/hast.65.
2
Genomic Contextualism: Shifting the Rhetoric of Genetic Exceptionalism.
Am J Bioeth. 2019 Jan;19(1):51-63. doi: 10.1080/15265161.2018.1544304.
3
Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
Clin J Oncol Nurs. 2014 Aug;18(4):437-41. doi: 10.1188/14.CJON.437-441.
4
Obesity Genes, Personalized Medicine, and Public Health Policy.
Curr Obes Rep. 2015 Sep;4(3):319-23. doi: 10.1007/s13679-015-0163-x.
5
Toward clinical genomics in everyday medicine: perspectives and recommendations.
Expert Rev Mol Diagn. 2016;16(5):521-32. doi: 10.1586/14737159.2016.1146593. Epub 2016 Feb 24.
6
Personalized medicine: are we there yet?
J Cardiovasc Transl Res. 2008 Mar;1(1):3-4. doi: 10.1007/s12265-008-9016-2. Epub 2008 Mar 25.
7
THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
Life Sci Soc Policy. 2020 Nov 1;16(1):12. doi: 10.1186/s40504-020-00107-1.
8
Understanding patient and provider perceptions and expectations of genomic medicine.
J Surg Oncol. 2015 Jan;111(1):9-17. doi: 10.1002/jso.23712. Epub 2014 Jul 3.
9
Precision Medicine: From Science To Value.
Health Aff (Millwood). 2018 May;37(5):694-701. doi: 10.1377/hlthaff.2017.1624.
10
Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?
Eur J Epidemiol. 2014 Jun;29(6):383-90. doi: 10.1007/s10654-014-9898-z. Epub 2014 Apr 12.
引用本文的文献
1
Slowing down decay: biological clocks in personalized medicine.
Front Sociol. 2023 Apr 17;8:1111071. doi: 10.3389/fsoc.2023.1111071. eCollection 2023.
2
Personal Genomes in Practice: Exploring Citizen and Healthcare Professionals' Perspectives on Personalized Genomic Medicine and Personal Health Data Spaces Using a Mixed-Methods Design.
Genes (Basel). 2023 Mar 24;14(4):786. doi: 10.3390/genes14040786.
3
Reimagining health services provision for neglected groups: The "personalization from below" phenomenon.
Front Sociol. 2023 Feb 2;8:1052215. doi: 10.3389/fsoc.2023.1052215. eCollection 2023.
4
The New Precision Stewards?
J Pers Med. 2022 Aug 12;12(8):1308. doi: 10.3390/jpm12081308.
5
Pursuing Public Health Benefit Within National Genomic Initiatives: Learning From Different Policies.
Front Genet. 2022 May 24;13:865799. doi: 10.3389/fgene.2022.865799. eCollection 2022.
6
The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing.
Hum Genet. 2022 May;141(5):1035-1043. doi: 10.1007/s00439-021-02269-0. Epub 2021 Mar 14.
7
Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues.
Genome Med. 2021 Jan 28;13(1):14. doi: 10.1186/s13073-021-00829-7.
8
From Expectations to Experiences: Consumer Autonomy and Choice in Personal Genomic Testing.
AJOB Empir Bioeth. 2020 Jan-Mar;11(1):63-76. doi: 10.1080/23294515.2019.1701583. Epub 2019 Dec 30.
9
Meeting the needs of underserved populations: setting the agenda for more inclusive citizen science of medicine.
J Med Ethics. 2019 Sep;45(9):617-622. doi: 10.1136/medethics-2018-105253. Epub 2019 Jul 12.
10
Genomic Essentialism: Its Provenance and Trajectory as an Anticipatory Ethical Concern.
Hastings Cent Rep. 2019 May;49 Suppl 1(Suppl 1):S10-S18. doi: 10.1002/hast.1012.
本文引用的文献
1
Opioid abuse in the United States and Department of Health and Human Services actions to address opioid-drug-related overdoses and deaths.
J Pain Palliat Care Pharmacother. 2015 Jun;29(2):133-9. doi: 10.3109/15360288.2015.1037530.
2
The contractual genome: how direct-to-consumer genomic services may help patients take ownership of their DNA.
Per Med. 2008 Jul 1;5(4):399-404. doi: 10.2217/17410541.5.4.399.
3
After the revolution? Ethical and social challenges in 'personalized genomic medicine'.
Per Med. 2012 Jun 1;9(4):429-439. doi: 10.2217/pme.12.37.
4
Predictive, personalized, preventive, participatory (P4) cancer medicine.
Nat Rev Clin Oncol. 2011 Mar;8(3):184-7. doi: 10.1038/nrclinonc.2010.227.
5
Personal genomics and individual identities: motivations and moral imperatives of early users.
New Genet Soc. 2010 Sep 1;29(3):261-290. doi: 10.1080/14636778.2010.507485.
6
Impact of communicating personalized genetic risk information on perceived control over the risk: a systematic review.
Genet Med. 2011 Apr;13(4):273-7. doi: 10.1097/GIM.0b013e3181f710ca.
7
Genetic risks and healthy choices: creating citizen-consumers of genetic services through empowerment and facilitation.
Sociol Health Illn. 2010 Mar;32(3):365-81. doi: 10.1111/j.1467-9566.2009.01202.x. Epub 2009 Nov 4.
8
Emerging patient-driven health care models: an examination of health social networks, consumer personalized medicine and quantified self-tracking.
Int J Environ Res Public Health. 2009 Feb;6(2):492-525. doi: 10.3390/ijerph6020492. Epub 2009 Feb 5.
9
Personal genomes: Misdirected precaution.
Nature. 2008 Nov 6;456(7218):34-5. doi: 10.1038/456034a.
10
Genomic profiles for disease risk: predictive or premature?
JAMA. 2008 Mar 19;299(11):1353-5. doi: 10.1001/jama.299.11.1353.
Zotero 插件